Jaime Merchan, MD, discusses the efficacy results observed in the LITESPARK-013 trial of belzutifan in patients with advanced clear cell renal cell carcinoma.

Before you plunk down hundreds of dollars for an infrared light device, know that the scientific evidence is not all in yet.

Adicet Bio has dosed the first subject in a multicentre Phase I trial of ADI-270, a gamma delta CAR T-cell therapy for treating ccRCC.

Surface reconstruction via nano-polishing enhances the efficiency and stability of wide-bandgap perovskite solar cells, ...

Thin-film solar cells are valued for their efficiency in material usage, requiring significantly less than traditional ...

Long before home video cameras became popular, Austin’s Highland Mall offered shoppers a way to record holiday greetings that ...

Microbes found in green spaces can transfer into your body, increasing bacterial diversity and potentially boosting the ...

The same strategy even worked to clear brain metastases of breast cancer." Milos Simic, PhD, the Valhalla Foundation Cell Design Fellow and co-first author of the paper In another experiment ...

Study analyzed global patterns and trends in ovarian cancer incidence from 1988 to 2017, highlighting variations by ...

Many toys that will be opened by little ones during the holidays will need batteries to operate. But those batteries pose a ...

Two lawmakers from California have asked the U.S. Department of Justice to investigate a violent incident at Men’s Central ...